Mirum Pharmaceuticals, Inc. 4

SVP, Global Controller Jolanda Howe sold 1,840 shares of Mirum Pharmaceuticals, Inc. common stock at $105.29 per share under a Rule 10b5-1 plan.

On August 3, 2026, Mirum Pharmaceuticals, Inc. SVP, Global Controller Jolanda Howe sold 1,840 shares of the company’s common stock at a price of $105.29 per share, for total proceeds of approximately $193,734. Following this Rule 10b5-1 plan trade, she directly holds 1,274 shares of Mirum common stock. The transaction appears to be a planned discretionary sale by an executive officer, modest in size relative to typical insider activity thresholds, with no additional derivative or award-related transactions disclosed in this Form 4.

Filing Facts

CIK

1759425

Ticker

MIRM

Form

4

Source Type

fda

Accession

0001974200-26-000011

Alert Tier

6